Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: Prostaglandin E2 regulates the migratory capacity of specific DC subsets

Blood

Volumn 100, Issue 4, 2002, Pages 1362-1372

  Luft, Thomas ^a,b,c,d,e   Jefford, Michael ^a,b,c,d,e   Luetjens, Petra ^a,b,c,d,e   Toy, Tracey ^a,b,c,d,e   Hochrein, Hubertus ^a,b,c,d,e   Masterman, Kelly Anne ^a,b,c,d,e   Maliszewski, Charlie ^a,b,c,d,e   Shortman, Ken ^a,b,c,d,e   Cebon, Jonathan ^a,b,c,d,e   Maraskovsky, Eugene ^a,b,c,d,e,f  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e AMGEN INC   (United States)

^f OLIVIA NEWTON JOHN CANCER RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CHEMOKINE RECEPTOR; CYCLIC AMP; CYTOKINE; PROSTAGLANDIN E2; PROSTANOID;

ARTICLE; CELL MIGRATION; CELL POPULATION; CELL STIMULATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; STIMULUS RESPONSE; T LYMPHOCYTE;

EID: 0037103261     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-12-0360     Document Type: Article

References (69)

1. Dendritic cells and the control of immunity
2. Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters
3. Distinct patterns and kinetics of chemokine production regulate dendritic cell function
4. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells
5. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization
6. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes
7. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
8. Interleukin-12: A cytokine at the interface of inflammation and immunity
9. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
10. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
11. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
12. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
13. High-level IL-12 production by human dendritic cells requires two signals
14. IL-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells
15. IL-4 is a mediator of IL-12p70 induction by human Th2 cells: Reversal of polarized Th2 phenotype by dendritic cells
16. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4
17. CD40 triggering of heterodimeric IL-12p70 production by dendritic cells in vivo requires a microbial priming signal
18. IL-1β induces dendritic cells to produce IL-12
19. IL-1β enhances CD40L-mediated cytokine secretion by human dendritic cells (DC): A mechanism for T cell independent DC activation
20. Interferon-alpha (IFN-α) enhances CD40L-mediated activation of immature MoDC
21. In vivo generation of dendritic cells by Flt3 ligand
22. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
23. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
24. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: Decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells
25. - dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation
26. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells
27. 2 is a selective inducer of interleukin 12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer
28. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
29. Type I IFNs enhance the terminal differentiation of dendritic cells
30. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production
31. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
32. Dendritic cell migration to lymph nodes: Cytokines, chemokines, and lipid mediators
33. 4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes
34. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation
35. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
36. Prostaglandin EP, receptor subtype selectivity takes shape
37. 2 receptors in human gingival fibroblasts
38. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation
39. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells
40. Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells
41. Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus
42. 2 production by DTH-initiating factors
43. The co-culture of dermal fibroblasts with human epidermal keratinocytes induces increased prostaglandin E2 production and cyclooxygenase 2 activity in fibroblasts
44. Cholecalciferol induces prostaglandin E2 biosynthesis and transglutaminase activity in human keratinocytes
45. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs
46. Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins
47. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
48. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis
49. Effects of prostaglandin E2 on mesangial cell migration
50. 2: Effects on corneal endothelial cell migration and monolayer spreading during wound repair in vitro
51. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis
52. Modulation of migration of Oesophagostomum dentatum larvae by inhibitors and products of eicosanoid metabolism
53. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1
54. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation
55. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells
56. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription
57. 2
58. Beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway
59. Prostaglandin production by macrophages and the effect of anti-inflammatory drugs
60. Uncoupling of inflammatory chemokine receptors by IL-10: Generation of functional decoys
61. Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells
62. The disabled dendritic cell
63. Human monocyte-derived dendritic cells are deficient in prostaglandin E2 production
64. Human thyroid fibroblasts exhibit a distinctive phenotype in culture: Characteristic ganglioside profile and functional CD40 expression
65. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1 + melanoma patients by mature monocyte-derived dendritic cells
66. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
67. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
68. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
69. + T cells activated in a T helper type 2-like response in vivo